Russian Direct Investment Fund
13 Apr 2021
India to get limited doses of Sputnik V by April-end
Sputnik V, the Russia-made coronavirus vaccine, will be manufactured in India by five pharmaceutical firms. It is estimated that 850 million doses will be produced yearly.
19 Mar 2021
Indian drugmaker to produce 200mn doses of Russia's Sputnik V
Stelis Biopharma, the biopharmaceutical arm of Bengaluru-based Strides Pharma Science, will be making and supplying at least 200 million doses of the Sputnik V vaccine, the Russian coronavirus vaccine currently awaiting emergency use approval in India.
22 Dec 2020
Russia, AstraZeneca to test combination of COVID-19 shots
Developers of the Russian coronavirus vaccine Sputnik V on Monday announced signing an agreement with AstraZeneca to test a combination of the British drug maker's COVID-19 shots and a component of the vaccine created in Moscow.
18 Dec 2020
COVID-19 vaccine: India to produce 300 million Sputnik V doses
India will reportedly produce around 300 million doses of the Russian COVID-19 vaccine called Sputnik V.
02 Dec 2020
Putin orders Russian authorities to start mass COVID-19 vaccinations
Russian President Vladimir Putin on Wednesday ordered authorities to start mass voluntary vaccinations for COVID-19.
27 Nov 2020
India to produce 100 million Sputnik V doses starting 2021
India will produce over 100 million doses a year of the Russian COVID-19 vaccine Sputnik V starting 2021, under an agreement between the Russian Direct Investment Fund (RDIF) and Hyderabad-based Hetero Biopharma, Hindustan Times reported.
24 Nov 2020
Russia's Sputnik V at least 91% effective, early data suggests
The Russian vaccine for COVID-19, called Sputnik V, has been found at least 91% effective in the second interim analysis.
22 Nov 2020
Russia's Sputnik V to start human trials in India soon
Russia's COVID-19 vaccine candidate, called Sputnik V, is expected to start human trials in India soon.
25 Oct 2020
Sputnik V Phase-II trials to have 100 volunteers: Dr. Reddy's
Phase II clinical trials for the Russian COVID-19 vaccine, Sputnik V, will have 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) has told Sputnik.
08 Oct 2020
India rejects large scale trial of Russia's COVID-19 vaccine
India's drug regulator has refused to allow a large scale clinical trial of Russia's Sputnik V COVID-19 vaccine.
18 Sep 2020
One in seven volunteers for Sputnik V report side effects
Sputnik V, the COVID-19 vaccine developed and approved by Russia, has shown side effects in some trial volunteers.
16 Sep 2020
Dr. Reddy's bringing coronavirus vaccine to India by 2020-end
In a major development, Hyderabad-based pharma company Dr. Reddy's Laboratories has partnered with the Russian Direct Investment Fund (RDIF) to source their Sputnik V COVID-19 vaccine for India.
21 Aug 2020
Russia looking to partner with India for COVID-19 vaccine production
Russia has been in the headlines for its two-month-tested 'Sputnik V' COVID-19 vaccine.
09 Aug 2020
Russia's COVID-19 vaccine candidate to be registered this week
Russian health officials are set to register a vaccine candidate for the novel coronavirus disease, COVID-19, as early as this week.